Newsletter
Newsletter Support JNS

Report: Israel reopens its skies with caveats

Israelis can fly to Greece, Bulgaria and Croatia, but must be tested for COVID-19 before flying and remain in quarantine upon arrival until receiving the results.

The departures hall at Ben-Gurion Airport, Aug. 16, 2020. Credit: Avshalom Sassoni/Flash90.
The departures hall at Ben-Gurion Airport, Aug. 16, 2020. Credit: Avshalom Sassoni/Flash90.

Israel on Sunday partially reopened its skies to incoming and outgoing flights, following months of closures due to the coronavirus pandemic.

According to a plan published by the Israeli government last week, those entering Israel from “green countries” will no longer be required to quarantine upon entry.

Israelis will be permitted to fly to Greece, Bulgaria and Croatia, but will need to be tested for COVID-19 before flying and will have to remain in quarantine upon arrival until the test results are received, according to Israel’s Channel 12 News.

Israelis and foreign residents will be allowed to arrive in Israel without the need to quarantine from Austria, Bulgaria, Canada, Croatia, Cyprus, Denmark, Estonia, Finland, Georgia, Germany, Greece, Hong Kong, Hungary, Italy, Latvia, Lithuania, New Zealand, Rwanda, Slovenia and the United Kingdom. However, entry to these countries will not be allowed with an Israeli passport.

In accordance with the plan, the list of countries accepting Israelis will be updated every two weeks. In addition, passengers from Israel must fill out a health declaration and details on both departure and return to Israel.

The regime “is in very bad shape” economically and cannot pay its troops due to the U.S. naval blockade on Iranian ports, said the U.S. president.
Nefesh B’Nefesh marks 100,000 “olim” from North America since 2002 with the Douglas family, who moved to Jerusalem from New York.
Some 109 votes separate Luc Jasmin III, whose father resigned from a state panel after making antisemitic remarks, and the Republican candidate.
The Tel Aviv-based drug maker is facing an antitrust lawsuit, together with several other pharmaceutical companies.